GO:0045953 negative regulation of natural killer cell mediated cytotoxicity: Immune Evasion, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045953 describes any biological process that stops, prevents, or reduces the rate of natural killer (NK) cell mediated cytotoxicity.
• Negative regulation of NK cytotoxicity is essential for preventing autoimmunity and limiting immunopathology, but it is also hijacked by tumors and viruses to escape immune surveillance.
• Key mechanisms include decoy receptor engagement, metabolic reprogramming, alternative splicing of effector molecules, and cytokine-mediated suppression.
• Cancer-associated fibroblasts can act as decoys that suppress NK cell anticancer cytotoxicity in breast cancer.
• Deletion of CISH, a negative regulator of NK cell signaling, enhances NK cell persistence and anti-tumor activity, demonstrating that removing inhibition boosts cytotoxicity.
• Alternative splicing of GSDMB modulates killer lymphocyte-triggered pyroptosis, revealing a post-transcriptional layer of negative regulation.
Description
Natural killer (NK) cells are innate lymphoid cells that mediate cytotoxicity against infected and transformed cells. The Gene Ontology term GO:0045953, negative regulation of natural killer cell mediated cytotoxicity, encompasses any process that stops, prevents, or reduces the rate of NK cell mediated killing. This regulatory axis is critical for maintaining immune homeostasis, preventing autoimmunity, and limiting collateral tissue damage during inflammation. However, pathogens and tumors exploit these same mechanisms to evade NK cell surveillance, making this GO term highly relevant to cancer immunology and infectious disease research. Understanding the molecular players that negatively regulate NK cytotoxicity is therefore essential for developing therapies that enhance NK cell function without causing autoimmunity.
negative regulation of natural killer cell mediated cytotoxicity At A Glance
| GO ID | GO:0045953 |
|---|---|
| GO term | negative regulation of natural killer cell mediated cytotoxicity |
| Ontology | biological_process |
| Synonym | inhibition of natural killer cell mediated cytotoxicity |
| Major function | Suppression of NK cell mediated killing of target cells |
| Related processes | Immune evasion, autoimmunity prevention, tumor microenvironment immunosuppression |
| Key regulators | CISH, GSDMB, interferons, miR-582, cancer-associated fibroblasts |
| Disease relevance | Cancer, HIV infection, autoimmune disorders |
What Is GO:0045953?
GO:0045953 is defined as any process that stops, prevents, or reduces the rate of natural killer mediated cytotoxicity. It includes mechanisms that inhibit NK cell activation, effector molecule release, or target cell killing, such as decoy receptor engagement, metabolic reprogramming, and cytokine-mediated suppression.
Why Is negative regulation of natural killer cell mediated cytotoxicity Important in Cell Biology?
Negative regulation of NK cell mediated cytotoxicity is a double-edged sword: it protects against autoimmunity and excessive inflammation but also enables tumors and viruses to escape immune destruction. Understanding this process is critical for designing immunotherapies that selectively enhance NK cell activity against cancer while preserving self-tolerance.
• Prevents autoimmunity by limiting NK cell attack on healthy tissues.
• Limits immunopathology during chronic viral infections such as HIV.
• Promotes tumor immune evasion in breast cancer and other malignancies.
• Metabolic reprogramming via CISH deletion enhances NK cell anti-tumor activity.
• Alternative splicing of GSDMB modulates killer lymphocyte-triggered pyroptosis.
• Interferons are major regulators of NK cell mediated cytotoxicity.
• miR-582 protects B-cell precursor acute lymphoblastic leukemia cells from NK cytotoxicity.
• CD24a knockout enhances macrophage- and CD8+ T cell-mediated anti-tumor immunity.
• Cord-blood derived CAR-NKT cells show potent antitumor activity, highlighting NK cell engineering.
• Cancer-associated fibroblasts act as decoys to suppress NK cell anticancer cytotoxicity.
What Happens During negative regulation of natural killer cell mediated cytotoxicity?
Decoy-mediated suppression by cancer-associated fibroblasts
In simple terms: Cancer-associated fibroblasts can act as fake targets that distract NK cells from killing real cancer cells.
In breast cancer, cancer-associated fibroblasts serve as decoys that suppress NK cell anticancer cytotoxicity, thereby reducing NK cell-mediated killing of tumor cells.
Metabolic reprogramming and CISH deletion
In simple terms: Removing a brake called CISH makes NK cells more persistent and better at killing tumors.
Metabolic reprogramming via deletion of CISH in human iPSC-derived NK cells promotes in vivo persistence and enhances anti-tumor activity, indicating that CISH negatively regulates NK cell cytotoxicity.
Alternative splicing of GSDMB
In simple terms: Different versions of the GSDMB protein can change how killer lymphocytes trigger cell death.
Alternative splicing of GSDMB modulates killer lymphocyte-triggered pyroptosis, revealing a post-transcriptional mechanism that can negatively regulate NK cell mediated cytotoxicity.
Interferon-mediated regulation
In simple terms: Interferons are signals that can turn down NK cell killing activity.
Interferon is a major regulator of natural killer cell-mediated cytotoxicity, and it can suppress NK cell function under certain conditions.
MicroRNA-mediated protection of leukemia cells
In simple terms: A small RNA called miR-582 can protect leukemia cells from being killed by NK cells.
miR-582 suppresses the proliferation of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) cells and protects them from natural killer cell-mediated cytotoxicity, demonstrating a microRNA-based negative regulatory mechanism.
Key Genes Involved in GO:0045953 negative regulation of natural killer cell mediated cytotoxicity
The following genes and proteins are experimentally implicated in the negative regulation of NK cell mediated cytotoxicity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CISH | Negative regulator of cytokine signaling; deletion enhances NK cell persistence and anti-tumor activity | Target for enhancing NK cell immunotherapy |
| GSDMB | Alternative splicing modulates killer lymphocyte-triggered pyroptosis | Post-transcriptional regulation of NK cytotoxicity |
| IFN | Interferon is a major regulator of NK cell-mediated cytotoxicity | Cytokine-mediated suppression of NK cells |
| miR-582 | Protects BCP-ALL cells from NK cell-mediated cytotoxicity | MicroRNA-based immune evasion |
| CD24a | Knockout enhances macrophage- and CD8+ T cell-mediated anti-tumor immune responses | Modulates tumor microenvironment immunity |
| Cancer-associated fibroblasts | Serve as decoys to suppress NK cell anticancer cytotoxicity | Tumor microenvironment-mediated NK suppression |
| CAR-NKT cells | Cord-blood CD34+ HSPC-derived mesothelin-specific CAR-NKT cells with potent antitumor activity | Engineered NK T cells for cancer therapy |
| NK cells | Negative regulation of NK cell mediated cytotoxicity in HIV infection | Two sides of a coin in HIV pathogenesis |
How Is negative regulation of natural killer cell mediated cytotoxicity Regulated?
Negative regulation of NK cell mediated cytotoxicity is controlled by multiple layers including cytokine signaling (e.g., interferons), metabolic checkpoints (e.g., CISH), alternative splicing of effector molecules (e.g., GSDMB), microRNAs (e.g., miR-582), and tumor microenvironment components such as cancer-associated fibroblasts. These regulators can act at the level of NK cell activation, effector molecule release, or target cell recognition.
negative regulation of natural killer cell mediated cytotoxicity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CISH | Cancer immunotherapy | CISH knockout iPSC-derived NK cells |
| GSDMB | Killer lymphocyte-triggered pyroptosis | GSDMB splicing isoform knock-in |
| miR-582 | B-cell precursor acute lymphoblastic leukemia | miR-582 overexpression in BCP-ALL cells |
| CD24a | Triple-negative breast cancer | CD24a knockout mouse model |
| Cancer-associated fibroblasts | Breast cancer | Co-culture with CAFs and NK cells |
Cancer immune evasion
Tumors exploit negative regulation of NK cell mediated cytotoxicity to escape immune destruction. Cancer-associated fibroblasts serve as decoys to suppress NK cell anticancer cytotoxicity in breast cancer. CD24a knockout results in enhanced macrophage- and CD8+ T cell-mediated anti-tumor immune responses in the tumor microenvironment in a murine triple-negative breast cancer model. Targeting triple-negative breast cancer using cord-blood CD34+ HSPC-derived mesothelin-specific CAR-NKT cells with potent antitumor activity demonstrates the therapeutic potential of overcoming NK inhibition.
HIV infection
Negative regulation and protective function of natural killer cells in HIV infection represent two sides of a coin, where NK cells can both control viral replication and contribute to immunopathology.
Leukemia
miR-582 suppresses the proliferation of B-cell precursor acute lymphoblastic leukemia (BCP-ALL) cells and protects them from natural killer cell-mediated cytotoxicity, highlighting a mechanism of leukemia immune evasion.
From negative regulation of natural killer cell mediated cytotoxicity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CISH negatively regulate NK cell cytotoxicity? | CISH knockout in human iPSC-derived NK cells |
| How does GSDMB splicing affect NK-triggered pyroptosis? | GSDMB splicing isoform knock-in |
| Does miR-582 protect leukemia cells from NK killing? | miR-582 overexpression in BCP-ALL cells |
| Does CD24a knockout enhance anti-tumor immunity? | CD24a knockout mouse model |
| Do cancer-associated fibroblasts suppress NK cytotoxicity? | Co-culture of CAFs with NK cells |
| Can CAR-NKT cells overcome NK inhibition? | Mesothelin-specific CAR-NKT cells |
How to Study the negative regulation of natural killer cell mediated cytotoxicity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cytotoxicity assay | NK cell killing of target cells | Quantifying negative regulation |
| Metabolomics | Metabolic reprogramming | CISH deletion effects |
| RNA-seq | Alternative splicing | GSDMB isoforms |
| miRNA overexpression | Protection from NK killing | miR-582 in BCP-ALL |
| Knockout mouse models | In vivo anti-tumor immunity | CD24a knockout |
| Co-culture assays | Decoy-mediated suppression | CAFs and NK cells |
| CAR-NKT engineering | Antitumor activity | Mesothelin-specific CAR-NKT |
Cytotoxicity assays
Standard chromium release or flow-based cytotoxicity assays measure the ability of NK cells to kill target cells, and are used to quantify negative regulation.
Metabolic profiling
Seahorse or metabolomics analyses assess metabolic reprogramming in NK cells, as shown for CISH deletion.
Splicing analysis
RNA-seq and RT-PCR are used to detect alternative splicing of GSDMB and its impact on pyroptosis.
MicroRNA functional studies
Overexpression or inhibition of miR-582 followed by NK co-culture evaluates its protective role in leukemia cells.
How CRISPR Can Be Used to Study GO:0045953 negative regulation of natural killer cell mediated cytotoxicity
Knockout
CRISPR knockout of CISH in human iPSC-derived NK cells enhances anti-tumor activity, demonstrating that removing negative regulators boosts NK cytotoxicity.
Point Mutation
Point mutations can be introduced to dissect signaling domains or splice sites in genes such as GSDMB to study their role in negative regulation.
Knock-in
Knock-in of specific splicing isoforms or reporter tags allows precise tracking of negative regulators like GSDMB in NK cells.
Overexpression
Overexpression of miR-582 in BCP-ALL cells protects them from NK cell-mediated cytotoxicity, validating its negative regulatory role.
How EDITGENE Supports negative regulation of natural killer cell mediated cytotoxicity Research
Researchers studying negative regulation of natural killer cell mediated cytotoxicity-related genes often need to determine whether a candidate gene is causally involved in suppressing NK cell killing. EDITGENE provides CRISPR-based cell model services to enable such functional studies.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of natural killer cell mediated cytotoxicity research.
Frequently Asked Questions About negative regulation of natural killer cell mediated cytotoxicity
What is negative regulation of natural killer cell mediated cytotoxicity?
It is any process that stops, prevents, or reduces the rate of NK cell mediated killing of target cells, defined as GO:0045953.
What genes are involved in negative regulation of NK cell mediated cytotoxicity?
Key genes include CISH, GSDMB, IFN, miR-582, and CD24a, as shown in various studies.
How do cancer-associated fibroblasts suppress NK cells?
They can act as decoys that distract NK cells from killing tumor cells, as demonstrated in breast cancer.
What is the role of CISH in NK cell cytotoxicity?
CISH is a negative regulator; its deletion enhances NK cell persistence and anti-tumor activity.
How does GSDMB alternative splicing affect NK cells?
Alternative splicing of GSDMB modulates killer lymphocyte-triggered pyroptosis, influencing NK cell mediated cytotoxicity.
Can interferons negatively regulate NK cell cytotoxicity?
Yes, interferon is a major regulator of NK cell-mediated cytotoxicity and can suppress NK cell function.
What is the role of miR-582 in leukemia immune evasion?
miR-582 protects B-cell precursor acute lymphoblastic leukemia cells from NK cell-mediated cytotoxicity.
Does CD24a knockout affect anti-tumor immunity?
CD24a knockout results in enhanced macrophage- and CD8+ T cell-mediated anti-tumor immune responses in a murine triple-negative breast cancer model.
How is negative regulation of NK cytotoxicity studied?
Methods include cytotoxicity assays, metabolic profiling, RNA-seq for splicing, and CRISPR knockout models.
What are the therapeutic implications of targeting negative regulation of NK cells?
Overcoming negative regulation can enhance NK cell anti-tumor activity, as shown with CISH deletion and CAR-NKT cells.
Conclusion
GO:0045953 negative regulation of natural killer cell mediated cytotoxicity is a critical biological process that balances immune protection and immune evasion. Understanding its molecular mechanisms, from CISH signaling to GSDMB splicing and microRNA regulation, offers opportunities for therapeutic intervention in cancer and infectious diseases. EDITGENE provides comprehensive CRISPR services to accelerate research in this field.
References
- 1. Ben-Shmuel A et al.. 2025. Cancer-Associated Fibroblasts Serve as Decoys to Suppress NK Cell Anticancer Cytotoxicity in Breast Cancer.. Cancer Discov 15(6):1247-1269 PMID: 40052789
- 2. Zhu H et al.. 2020. Metabolic Reprograming via Deletion of CISH in Human iPSC-Derived NK Cells Promotes In Vivo Persistence and Enhances Anti-tumor Activity.. Cell Stem Cell 27(2):224-237.e6 PMID: 32531207
- 3. Kong Q et al.. 2023. Alternative splicing of GSDMB modulates killer lymphocyte-triggered pyroptosis.. Sci Immunol 8(82):eadg3196 PMID: 37115914
- 4. Li YR et al.. 2025. Targeting triple-negative breast cancer using cord-blood CD34⁺ HSPC-derived mesothelin-specific CAR-NKT cells with potent antitumor activity.. J Hematol Oncol 18(1):86 PMID: 41077583
- 5. Reiter Z. 1993. Interferon--a major regulator of natural killer cell-mediated cytotoxicity.. J Interferon Res 13(4):247-57 PMID: 7693829
- 6. Sun Y et al.. 2022. Negative Regulation and Protective Function of Natural Killer Cells in HIV Infection: Two Sides of a Coin.. Front Immunol 13:842831 PMID: 35320945
- 7. Li X et al.. 2022. miR-582 Suppresses the Proliferation of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells and Protects Them From Natural Killer Cell-Mediated Cytotoxicity.. Front Immunol 13:853094 PMID: 35514986
- 8. Chan SH et al.. 2025. CD24a knockout results in an enhanced macrophage- and CD8⁺ T cell-mediated anti-tumor immune responses in tumor microenvironment in a murine triple-negative breast cancer model.. J Biomed Sci 32(1):73 PMID: 40783744
